Locations:
Search IconSearch

eDosimetry Consult Service Helps Design Treatment Plans From Afar

Complex patients benefit from expert dosimetry teams

eDosimetry_650x450

Identification of optimal dosing for multifocal cancers or cancers around sensitive organs can prove difficult for cancer treatment teams, whose ideal approach balances tumor lysing with healthy tissue sparing.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Such was the case of a recent bilateral breast cancer patient, whose trimodality treatment necessitated radiation around the sternum, heart and lungs.

The patient is a 54-year-old female who presented with bilateral breast-infiltrating ductal carcinoma with 1.3 cm mass in the right breast and 3.4 cm mass in the left breast. Treatment included radiation, in addition to neoadjuvant chemotherapy with trastuzumab, pertuzumab, docetaxol and carboplatin. After chemotherapy, she underwent bilateral mastectomies with expander reconstruction.

“Like many of the more difficult cases we see, this patient posed a challenge in that our treatment team was committed to curing her cancer while also positioning her for the most fulfilling life possible after she walked out the door,” says Ping Xia, PhD, head of Medical Physics in the Department of Radiation Oncology.

Senior medical dosimetrist Eric Murray, under guidance of Dr. Xia, designed the following radiation treatment plan, which minimized exposure to critical organs while maximizing therapeutic effect:

  • Total dose 5040cGy with boost plan to PET post sternum and neck
  • Single isocenter IMRT
  • PET Positive Sternal Met, bilateral axillas and supraclavs and R Neck
  • Whole Lung V20 35%
  • Heart mean dose 600cGy

This planning CT scan of a bilateral breast cancer patient shows radiation exposure levels and was designed by the Medical Dosimetry team at Cleveland Clinic. At the time of publication, the patient remains disease free with fully functional organs

This planning CT scan of a bilateral breast cancer patient shows radiation exposure levels and was designed by the Medical Dosimetry team at Cleveland Clinic. At the time of publication, the patient remains disease free with fully functional organs.

image2_615x615

Treatment planning in dosimetry as piece of treatment puzzle

As oncology moves toward treating the entire patient, including quality-of-life considerations and overall wellness after treatment, treatment planning in dosimetry has emerged as an important piece of the treatment puzzle.

Advertisement

Patients and treatment teams rely on radiation oncologists, physicists and dosimetrists to craft individualized therapeutic plans that deliver favorable outcomes measured not only by disease-free survival but also by overall patient health and wellness.

In challenging cases, such as bilateral breast, head and neck, brain and other malignancies arising in sensitive areas, dosimetry teams are positioned to serve as critical participants in the treatment planning process.

However, hospitals and clinics outside major metropolitan areas often lack the patient volume to justify dedicated dosimetry personnel. Additionally, treatment centers with only one or two full-time dosimetrists remain subject to issues of staff turnover, burnout and family and medical leave.

These staffing gaps are frequently addressed through traveling contractors or remote dosimetry services. Traveling dosimetrists can be expensive, not only because of staff time but also because rates typically include travel, lodging, per diems and other ancillary expenses. These costs either must be shifted to the patient or absorbed by the treating institution. Neither choice offers particularly attractive solutions.

eDosimetry solutions

Cleveland Clinic now offers the dosimetry services provided to the patient described above to any institution anywhere in the world through its eDosimetry Consult Service.

This service allows all laboratory, imaging and treatment to be completed at the patient’s location of preference—usually somewhere close to home—while the dose planning and treatment design is completed at Cleveland Clinic by a team of more than a dozen experienced professionals.

Advertisement

When treatment teams in remote locations request services, radiologists at the treating institution are asked to complete a CT scan for planning purposes, which the eDosimetry Team can use to design treatment plans in collaboration with current providers.

The process is flexible and designed to be as integrative or hands off as needed to match the needs of the requesting organization and their patients. Dosimetrists need not travel. Patients receive optimal care in place. Communication and file transfers are secure and HIPAA compliant. Treatment teams can be confident in the expertise of Cleveland Clinic’s providers, and patients from any institution can benefit.

Advertisement

Related Articles

Male patient with doctor
June 17, 2026/Cancer/Patient Support

Overcoming Taboos: Helping Men with Cancer Restore Sexual Health

Creating a safe space for patients

Masked patient with physician
June 15, 2026/Cancer/Patient Support

Managing Infection Risk in the Era of Cell Therapy

Long-term immune effects reshape preventative strategies and timelines

Immune checkpoint inhibitor illustration
June 12, 2026/Cancer/News & Insight

Immunotherapy Appears to Reduce the Risk of Secondary Primary Cancers

Large-scale database also reveals potential for immunotherapy to protect against cancer

T53 mutation illustration
June 10, 2026/Cancer/News & Insight

TP53 Mutation Acquisition Timing Influences Prognosis in Myeloproliferative Neoplasms

Findings may help guide discussions around prognosis and allogeneic stem cell transplantation

Woman consoling another
June 5, 2026/Cancer/Blood Cancers

Equal Access to Modern Therapy May Help Eliminate Survival Differences in Multiple Myeloma

Research underscores the importance of access to timely diagnosis and treatment in this patient population.

Multiple myeloma cells
June 4, 2026/Cancer/Blood Cancers

Machine Learning Model Outperforms Standard Risk Tools for Multiple Myeloma

A Cleveland Clinic model combining clinical staging, genomics and AI predicts survival with 18% greater accuracy — and could help match patients to more effective treatments.

Dr. Kamath & colleagues in the lab
June 2, 2026/Cancer/News & Insight

Tissue Tumor Mutation Burden Outperforms Blood-Based Testing for Predicting Immunotherapy Response

Study serves as ‘cautionary tale’ for physicians tempted to rely on liquid biopsy results alone

Patient with nebulizer
June 1, 2026/Cancer/Innovations

Adding Novel Inhaled Agent May Improve Lung Cancer Outcomes

Direct delivery of viral-based vector KB707 to the lungs may boost anti-tumor response and help overcome immune checkpoint inhibitor resistance

Ad